Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

19 Aug 2014

Abstract excerpt

// Zachary C. Dobbin 1,2 , Ashwini A. Katre 1 , Adam D. Steg 1 , Britt K. Erickson 1 , Monjri M. Shah 1 , Ronald D. Alvarez 1 , Michael G. Conner 3 , David Schneider 4 , Dongquan Chen 5 and Charles N. Landen 6 1 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham 2 NIH Medical Scientist Training Program, University of Alabama at Birmingham 3 Department of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Ovarian cancer diagnosis and treatment
Share to Reproductive Biology and Fertility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25209969
DOI: 10.18632/oncotarget.2373

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerPMID 25209969Read ↗

Maintaining Tumor Heterogeneity in Patient-Derived Tumor XenograftsSemantic proximity Read ↗

Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian CancerSemantic proximity Read ↗

The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significanceSemantic proximity Read ↗

Biomarker-guided treatment strategies for ovarian cancer identified from a heterogeneous panel of patient-derived tumor xenograftsSemantic proximity Read ↗

Modeling platinum resistance in a stem-like patient-derived ovarian cancer sampleSemantic proximity Read ↗

Tumorigenicity of Ascites-Derived Tumor Cells: Insights Into the Molecular Mechanisms of Ovarian Cancer Progression and Therapy ResistanceSemantic proximity Read ↗

Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparibSemantic proximity Read ↗

Intratumoral Heterogeneity in the Self‐Renewal and Tumorigenic Differentiation of Ovarian CancerSemantic proximity Read ↗

Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug ResponsesSemantic proximity Read ↗

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical responseSemantic proximity Read ↗

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.Semantic proximity Read ↗

A Genomically Characterized Collection of High-Grade Serous Ovarian Cancer Xenografts for Preclinical Testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.